iECURE (Series A-1)
Funding Details
Awarder
Inbox
Date Award
November 30, 2022
Vertical
Gene Editing
Funding URL
View Funding Page
Funding Amount
$65,000,000
Company Info
Founders
Joseph Truitt
Market
Liver Disorders
Location
Plymouth Meeting, PA, USA
Coinvestors
LYFE Capital, Novo Holdings, OrbiMed Advisors, Versant Ventures
Company Description

iECURE is a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high unmet needs.

Links
WebsiteCrunchbaseLinkedIn
Back to HomeBack to Gene Editing DealsView Funding Announcement